Patient 3 had an ER-positive, PR-positive, HER2-positive (IHC score, 3+) right-breast mixed ductal and lobular invasive carcinoma diagnosed in 2021, with de novo metastatic disease to the right axillary nodes, liver, and bones. This evidence concerns the gene ERBB2 and invasive lobular breast carcinoma.